Cargando…

Prevention of colitis-associated colon cancer using a vaccine to target abnormal expression of the MUC1 tumor antigen

Association between chronic inflammation and cancer development is exemplified by inflammatory bowel disease (IBD) where patients with chronic uncontrolled colitis have a significantly increased risk of developing colitis-associated colorectal cancer (CACC). CACC appears to progresses through the in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beatty, Pamela, Ranganathan, Sarangarajan, Finn, Olivera J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382848/ https://www.ncbi.nlm.nih.gov/pubmed/22737601 http://dx.doi.org/10.4161/onci.18950

Ejemplares similares

Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-κB p65 and EzH2, in colitis-associated cancer
por: Cascio, Sandra, et al.
Publicado: (2017)

Complex of MUC1, CIN85 and Cbl in Colon Cancer Progression and Metastasis
por: Cascio, Sandra, et al.
Publicado: (2015)

Early in vivo signaling profiles in MUC1-specific CD4(+) T cells responding to two different MUC1-targeting vaccines in two different microenvironments
por: Reichenbach, Dawn K., et al.
Publicado: (2013)

Muc5ac Expression Protects the Colonic Barrier in Experimental Colitis
por: Olli, Kristine E, et al.
Publicado: (2020)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells
por: Murwanti, Retno, et al.
Publicado: (2023)

Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen
por: Hillman, Gilda G., et al.
Publicado: (2017)

MUC Gene Abnormalities in Sporadic and Hereditary Mucinous Colon Cancers with Microsatellite Instability
por: Pastrello, Chiara, et al.
Publicado: (2005)

Intra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and Metastasis
por: Cascio, Sandra, et al.
Publicado: (2016)

MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis
por: Yao, Dianbo, et al.
Publicado: (2021)

Complex Carbohydrates Are Not Removed During Processing of Glycoproteins by Dendritic Cells: Processing of Tumor Antigen MUC1 Glycopeptides for Presentation to Major Histocompatibility Complex Class II–restricted T Cells
por: Vlad, Anda M., et al.
Publicado: (2002)

Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus
por: Mizoshita, Tsutomu, et al.
Publicado: (2013)

A165 FCGBP IN THE COLON IS SPATIALLY DEPENDENT ON MUC2 EXPRESSION AND IS DEGRADED IN DEXTRAN SULFATE SODIUM-INDUCED COLITIS
por: Kim, A, et al.
Publicado: (2023)

Introduction to the special issue: Tumor antigens in the time of the coronavirus pandemic
por: Finn, Olivera J.
Publicado: (2020)

Muc2 Protects against Lethal Infectious Colitis by Disassociating Pathogenic and Commensal Bacteria from the Colonic Mucosa
por: Bergstrom, Kirk S. B., et al.
Publicado: (2010)

Pathology of Podocytopathies Causing Nephrotic Syndrome in Children
por: Ranganathan, Sarangarajan
Publicado: (2016)

Anti-MUC1 Antibody in Nipple Aspirate Fluids Correlates with Tumor Aggressiveness in Breast Cancer: A Feasibility Study
por: Menekse, Ebru, et al.
Publicado: (2015)

Premalignant Lesions as Targets for Cancer Vaccines
por: Finn, Olivera J.
Publicado: (2003)

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
por: Lakshminarayanan, Vani, et al.
Publicado: (2016)

Molecular Mimics of the Tumour Antigen MUC1
por: James, Tharappel C., et al.
Publicado: (2012)

TG4010: A therapeutic vaccine against MUC1 expressing tumors
por: Limacher, Jean-Marc, et al.
Publicado: (2012)

Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines
por: Çuburu, Nicolas, et al.
Publicado: (2022)

Alterations in Mucin Expression in Ovarian Mucinous Tumors: Immunohistochemical Analysis of MUC2, MUC5AC, MUC6, and CD10 Expression
por: Hirabayashi, Kenichi, et al.
Publicado: (2008)

Spontaneous Colitis in Muc2-Deficient Mice Reflects Clinical and Cellular Features of Active Ulcerative Colitis
por: Wenzel, Ulf A., et al.
Publicado: (2014)

Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer
por: Witalison, Erin E., et al.
Publicado: (2015)

Teratoid Hepatoblastoma—Our Experience
por: Berklite, Lara, et al.
Publicado: (2022)

The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines
por: Liu, Yonghui, et al.
Publicado: (2021)

Rescuing Dicer expression in inflamed colon tissues alleviates colitis and prevents colitis-associated tumorigenesis
por: Wu, Xiaoli, et al.
Publicado: (2020)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

Global Inhibition of DC Priming Capacity in the Spleen of Self-Antigen Vaccinated Mice Requires IL-10
por: Marvel, Douglas M., et al.
Publicado: (2014)

Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration
por: Cascio, Sandra, et al.
Publicado: (2013)

Expression of MUC1 and MUC4 in Gallbladder Adenocarcinoma
por: Kim, Su-Mi, et al.
Publicado: (2012)

Decreased expression of MUC2 due to a decrease in the expression of lectins and apoptotic defects in colitis patients
por: Wibowo, Agung A., et al.
Publicado: (2019)

Development of a Serum Biomarker Assay That Differentiates Tumor-Associated MUC5AC (NPC-1C ANTIGEN) from Normal MUC5AC
por: Luka, Janos, et al.
Publicado: (2011)

Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice
por: Curry, Jennifer M., et al.
Publicado: (2019)

The expression and significance of Gal-3 and MUC1 in colorectal cancer and colon cancer
por: Wang, Hong-shan, et al.
Publicado: (2015)

LCVM infection generates tumor antigen-specific immunity and inhibits growth of nonviral tumors
por: Jacqueline, Camille, et al.
Publicado: (2022)

Development of synthetic, self-adjuvanting, and self-assembling anticancer vaccines based on a minimal saponin adjuvant and the tumor-associated MUC1 antigen
por: Pifferi, Carlo, et al.
Publicado: (2023)

Muc5b-deficient mice develop early histological lung abnormalities
por: Valque, Hélène, et al.
Publicado: (2019)

Muc5b Contributes to Mucus Abnormality in Rat Models of Cystic Fibrosis
por: Keith, Johnathan D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e7cai2u43t8dbhljifgv2vmeg7